ATE525098T1 - Verwendung von gelatine und transglutaminase zur herstellung eines vernetzenden medizinischen klebers - Google Patents

Verwendung von gelatine und transglutaminase zur herstellung eines vernetzenden medizinischen klebers

Info

Publication number
ATE525098T1
ATE525098T1 AT07785971T AT07785971T ATE525098T1 AT E525098 T1 ATE525098 T1 AT E525098T1 AT 07785971 T AT07785971 T AT 07785971T AT 07785971 T AT07785971 T AT 07785971T AT E525098 T1 ATE525098 T1 AT E525098T1
Authority
AT
Austria
Prior art keywords
cross
gelatin
transglutaminase
produce
linking
Prior art date
Application number
AT07785971T
Other languages
German (de)
English (en)
Inventor
Christoph Gaissmaier
Michael Ahlers
Original Assignee
Gelita Ag
Tetec Tissue Engineering Technologies Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelita Ag, Tetec Tissue Engineering Technologies Ag filed Critical Gelita Ag
Application granted granted Critical
Publication of ATE525098T1 publication Critical patent/ATE525098T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/104—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT07785971T 2006-07-10 2007-07-10 Verwendung von gelatine und transglutaminase zur herstellung eines vernetzenden medizinischen klebers ATE525098T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006033167A DE102006033167A1 (de) 2006-07-10 2006-07-10 Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung eines vernetzenden medizinischen Klebers
PCT/EP2007/006105 WO2008006545A2 (de) 2006-07-10 2007-07-10 Verwendung von gelatine und einem vernetzungsmittel zur herstellung eines vernetzenden medizinischen klebers

Publications (1)

Publication Number Publication Date
ATE525098T1 true ATE525098T1 (de) 2011-10-15

Family

ID=38596783

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07785971T ATE525098T1 (de) 2006-07-10 2007-07-10 Verwendung von gelatine und transglutaminase zur herstellung eines vernetzenden medizinischen klebers

Country Status (7)

Country Link
US (1) US9295751B2 (cg-RX-API-DMAC7.html)
EP (1) EP2037972B1 (cg-RX-API-DMAC7.html)
JP (1) JP5204103B2 (cg-RX-API-DMAC7.html)
AT (1) ATE525098T1 (cg-RX-API-DMAC7.html)
DE (1) DE102006033167A1 (cg-RX-API-DMAC7.html)
ES (1) ES2370095T3 (cg-RX-API-DMAC7.html)
WO (1) WO2008006545A2 (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006033168A1 (de) 2006-07-10 2008-01-17 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung
CN103933606B (zh) 2006-12-15 2016-08-24 生命连结有限公司 明胶-转谷氨酰胺酶止血敷料和密封材料
US8133484B2 (en) 2006-12-15 2012-03-13 Lifebond Ltd Hemostatic materials and dressing
US8367388B2 (en) 2008-06-18 2013-02-05 Lifebond Ltd. Cross-linked compositions
US20110112573A1 (en) * 2008-06-18 2011-05-12 Orahn Preiss Bloom Methods and devices for use with sealants
US20110104280A1 (en) * 2009-05-20 2011-05-05 Olexander Hnojewyj Wound treatment systems, devices, and methods using biocompatible synthetic hydrogel compositions
EP2710892B1 (en) 2009-07-21 2016-12-14 Marrone Bio Innovations, Inc. Use of sarmentine and its analogs for controlling weeds
AU2010334412B2 (en) 2009-12-22 2016-02-04 Lifebond Ltd Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
CA2807012A1 (en) 2010-08-05 2012-02-09 Lifebond Ltd. Dry composition wound dressings and adhesives
JP2012095769A (ja) * 2010-10-29 2012-05-24 Gunze Ltd 医療用接着剤及び医療用材料
US20130224712A1 (en) * 2012-02-24 2013-08-29 Bradford L. Day Medical training kits and methods to simulate treatment of uncontrolled hemorrhage
US10064973B2 (en) 2013-01-18 2018-09-04 National Institute For Materials Science Tissue adhesive and method for producing same
GB2515749B (en) * 2013-07-01 2016-08-31 Biodynamic Armor Ltd Pressure impulse mitigation
US10814032B2 (en) * 2014-08-08 2020-10-27 The Brigham And Women's Hospital, Inc. Elastic biopolymer and use as a tissue adhesive
US10723783B2 (en) 2015-03-19 2020-07-28 The Brigham And Women's Hospital, Inc. Polypeptide compositions and methods of using the same
WO2017139318A1 (en) 2016-02-08 2017-08-17 The Brigham And Women's Hospital, Inc. Bioadhesive for corneal repair
SI3455425T1 (sl) * 2016-05-13 2021-11-30 Rockwool International A/S Metoda za zagotavljanje izolacije strukture
US11679177B2 (en) 2017-08-08 2023-06-20 Baxter International Inc. Polymeric compositions, delivery devices, and methods
US10738175B2 (en) * 2017-08-15 2020-08-11 Sanford, L.P. Glue slime activator and associated methods and kits
CN110997781A (zh) * 2017-08-15 2020-04-10 桑福德有限合伙人公司 胶水史莱姆活化剂及相关方法和试剂盒
WO2019064290A1 (en) 2017-09-29 2019-04-04 Lifebond Ltd. COMPOSITION AND METHOD FOR CONTROLLED RELEASE OF MEDICINE FROM TISSUE
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices
WO2020051133A1 (en) 2018-09-04 2020-03-12 Massachusetts Eye And Ear Infirmary Light activated adhesive scaffold
CN110917389B (zh) * 2018-09-20 2022-03-22 广州迈普再生医学科技股份有限公司 一种组织封闭组合物、组织封堵胶及其制备方法
EP3904377B1 (en) * 2018-12-26 2023-08-02 National Institute for Materials Science Powder, wound-covering material, adhesion prevention material, hemostatic material, and production method for powder
CN112245411B (zh) * 2020-10-16 2023-06-16 中山大学附属口腔医院 一种普适性口腔绷带及其制备方法
CN112646205A (zh) * 2020-12-10 2021-04-13 南昌大学 一种增强鱼皮明胶凝胶强度的方法
CN115068666B (zh) * 2021-03-10 2023-12-26 广东粤港澳大湾区国家纳米科技创新研究院 一种防粘连的止血水凝胶及其制备方法和应用
JPWO2024154679A1 (cg-RX-API-DMAC7.html) * 2023-01-16 2024-07-25
CN117122729A (zh) * 2023-08-31 2023-11-28 太原理工大学 一种组织粘附性水凝胶的制备方法及其应用
WO2025069742A1 (ja) * 2023-09-28 2025-04-03 大日精化工業株式会社 生分解性接着剤組成物、及び生分解性接着剤組成物キット
CN119345119B (zh) * 2024-12-25 2025-04-08 四川大学华西医院 多功能水凝胶、载药水凝胶及其制备方法和应用

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581020A (en) * 1983-07-18 1986-04-08 Trimedyne, Inc. Medication delivery device and system for percutaneous administration of medication
JPS61152247A (ja) 1984-12-26 1986-07-10 Ajinomoto Co Inc 蛋白質膜の製造法
US5936035A (en) 1988-11-21 1999-08-10 Cohesion Technologies, Inc. Biocompatible adhesive compositions
US5385606A (en) 1992-07-06 1995-01-31 Kowanko; Nicholas Adhesive composition and method
US5549904A (en) 1993-06-03 1996-08-27 Orthogene, Inc. Biological adhesive composition and method of promoting adhesion between tissue surfaces
US5939385A (en) 1993-08-13 1999-08-17 Zymogenetics, Inc. Transglutaminase cross-linkable polypeptides and methods relating thereto
US5428014A (en) 1993-08-13 1995-06-27 Zymogenetics, Inc. Transglutaminase cross-linkable polypeptides and methods relating thereto
DE69426530D1 (de) 1993-10-04 2001-02-08 Maurizio Tonetti Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
FR2715309B1 (fr) * 1994-01-24 1996-08-02 Imedex Composition adhésive, à usage chirurgical, à base de collagène modifié par coupure oxydative et non réticulé.
WO1996010374A1 (en) 1994-10-03 1996-04-11 Otogen Corporation Differentially biodegradable biomedical implants
FR2726571B1 (fr) * 1994-11-03 1997-08-08 Izoret Georges Colle biologique, procede de preparation et dispositif d'application pour colle biologique, et durcisseurs pour colle biologique
DE19508192A1 (de) * 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung
US6565842B1 (en) 1995-06-07 2003-05-20 American Bioscience, Inc. Crosslinkable polypeptide compositions
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US5589322A (en) * 1995-12-12 1996-12-31 Eastman Kodak Company Process for making a direct dispersion of a photographically useful material
WO1997029715A1 (en) * 1996-02-20 1997-08-21 Fusion Medical Technologies, Inc. Compositions and methods for sealing tissue and preventing post-surgical adhesions
ATE439849T1 (de) 1996-04-19 2009-09-15 Osiris Therapeutics Inc Die wiederherstellung und verstärkung von knochen mittels mesenchymalen stammzellen
US5834232A (en) 1996-05-01 1998-11-10 Zymogenetics, Inc. Cross-linked gelatin gels and methods of making them
US6039901A (en) * 1997-01-31 2000-03-21 Givaudan Roure Flavors Corporation Enzymatically protein encapsulating oil particles by complex coacervation
US20020098222A1 (en) 1997-03-13 2002-07-25 John F. Wironen Bone paste
DE19732917C1 (de) 1997-07-30 1998-10-15 Fuchsbauer Hans Lothar Verfahren zum Transglutaminase-katalysierten Koppeln von Protein oder Peptid an einen Träger
US20020076429A1 (en) 1998-01-28 2002-06-20 John F. Wironen Bone paste subjected to irradiative and thermal treatment
US20040036054A1 (en) * 1998-06-29 2004-02-26 Haslim Leonard Arthur Environmentally friendly compositions having antiicing, deicing or graffiti prevention properties
US20020015724A1 (en) * 1998-08-10 2002-02-07 Chunlin Yang Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
ATE324831T1 (de) 1998-08-26 2006-06-15 Neomend Inc Kit zur in-situ-erzeugung chemisch verbundener mechanischer barrieren oder abdeckstrukturen für eine punktionsstelle in einem blutgefäss
ATE296122T1 (de) 1999-07-21 2005-06-15 Imedex Biomateriaux Eiweissschaum klebstoff zur chirurgischen und/oder therapeutischen verwendung
US20030095993A1 (en) * 2000-01-28 2003-05-22 Hanne Bentz Gel-infused sponges for tissue repair and augmentation
AU2002221370A1 (en) 2000-11-15 2002-05-27 Bio Syntech Canada Inc Method for restoring a damaged or degenerated intervertebral disc
PL362606A1 (en) * 2000-11-28 2004-11-02 Wyeth Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
US6685626B2 (en) * 2001-02-02 2004-02-03 Regeneration Technologies, Inc. Compositions, devices, methods, and kits for induction of adhesions
US8182527B2 (en) * 2001-05-07 2012-05-22 Cordis Corporation Heparin barrier coating for controlled drug release
DE10152407A1 (de) 2001-10-24 2003-05-08 Aesculap Ag & Co Kg Zusammensetzung aus mindestens zwei biokompatiblen chemisch vernetzbaren Komponenten
SE0200010D0 (sv) * 2002-01-02 2002-01-02 Amersham Biosciences Ab A method of producing hierarchical porous beads
DE60323943D1 (de) 2002-02-21 2008-11-20 Encelle Inc Immobilisierte bioaktive hydrogel matrizen für oberflächenbeschichtungen
US7138373B2 (en) * 2002-09-26 2006-11-21 University Of Maryland, Baltimore County Polysaccharide-based polymers and methods of making the same
JP2004283371A (ja) * 2003-03-20 2004-10-14 Nagoya Industrial Science Research Inst 医用材料
ES2318339T3 (es) 2003-08-29 2009-05-01 Mayo Foundation For Medical Education And Research Agentes formadores de poros a base de hidrogel para la construccion de estructuras biodegradables.
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
US9241902B2 (en) * 2003-12-17 2016-01-26 R.P. Scherer Technologies, Llc Chewable soft capsules containing ungelatinized starch
DE102004024635A1 (de) 2004-05-12 2005-12-08 Deutsche Gelatine-Fabriken Stoess Ag Verfahren zur Herstellung von Formkörpern auf Basis von vernetzter Gelatine
WO2005115494A2 (en) 2004-05-27 2005-12-08 Humanitas Mirasole S.P.A. Use of fibrin for separating body organs
WO2006059984A1 (en) 2004-11-30 2006-06-08 The Regents Of The University Of Michigan Modified porous materials and method of forming the same
US7837986B2 (en) * 2004-12-01 2010-11-23 E. I. Du Pont De Nemours And Company Protein-based polymer tissue adhesives for medical use
DE102005054938A1 (de) 2005-11-17 2007-05-24 Gelita Ag Formkörper auf Basis eines vernetzten, Gelatine enthaltenden Materials, Verfahren zu deren Herstellung sowie deren Verwendung
RU2396000C2 (ru) * 2005-12-21 2010-08-10 Вм. Ригли Дж. Компани Кондитерский продукт в оболочке и способ его получения
DE102006033168A1 (de) * 2006-07-10 2008-01-17 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung
JP2011516541A (ja) * 2008-04-07 2011-05-26 ナショナル インスティテュート オブ イミュノロジー 糖尿病および他の慢性疾患の治療に有用な組成物

Also Published As

Publication number Publication date
EP2037972A2 (de) 2009-03-25
US20090175946A1 (en) 2009-07-09
JP2009542384A (ja) 2009-12-03
US9295751B2 (en) 2016-03-29
EP2037972B1 (de) 2011-09-21
ES2370095T3 (es) 2011-12-12
JP5204103B2 (ja) 2013-06-05
WO2008006545A2 (de) 2008-01-17
WO2008006545A8 (de) 2009-01-29
WO2008006545A3 (de) 2008-12-04
DE102006033167A1 (de) 2008-01-24

Similar Documents

Publication Publication Date Title
ATE525098T1 (de) Verwendung von gelatine und transglutaminase zur herstellung eines vernetzenden medizinischen klebers
ATE510569T1 (de) Verwendung von gelatine und einem vernetzungsmittel zur herstellung einer vernetzenden therapeutischen zusammensetzung
ATE402663T1 (de) Flächiges implantat
BRPI0410185A (pt) composição para manter a viabilidade de um orgão e célula
MX2009006369A (es) Apositos y selladores hemostaticos de gelatina-transglutaminasa.
DE60323323D1 (de) Sterilisation von Kits mit medizinischen Klebstoffzusammensetzungen
BRPI0818183A2 (pt) reparo e regeneração do tecido renal usando células derivadas do tecido do cordão umbilical humano
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE602005021372D1 (de) Zusammensetzung in mikropellets mit kontrollierter freisetzung von physiologischen wirksubstanzen, verfahren zu ihrer herstellung und ihre verwendung im zootechnischen sektor
EA200501562A1 (ru) Медицинские имплантаты, содержащие биосовместимые покрытия
UA102669C2 (xx) Застосування інгібіторів dpp iv$применение ингибиторов dpp iv
DOP2006000179A (es) 7-aza-indazoles sustituidos, composiciones que les contienen, procedimiento de fabricación y utilización
CY1116344T1 (el) Κυτταρα προερχομενα απο ιστο ομφαλιου λωρου για την θεραπεια νευροπαθητικου πονου και σπαστικοτητας
BR0315666A (pt) Dna de a34 e a33 do tipo 3, proteìnas, seus anticorpos e métodos de tratamento usando os mesmos
NZ591137A (en) Methods and systems for predicting response of cells to a therapeutic agent
BRPI0507169A (pt) polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
DE502007002289D1 (de) Methacrylatharze zur herstellung von fahrbahnmarkierungen
CY1112383T1 (el) Αναστολεις της πρωτεϊνης ενεργοποιησης της 5-λιποξυγενασης (flap)
WO2008069919A3 (en) Methods & compositions for treating tissue using silk proteins
ATE455463T1 (de) Verfahren zur herstellung gefriergetrockneter blutplättchen, gefriergetrocknete blutplättchen enthaltende zusammensetzungen und verwendungsverfahren
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
ATE552864T1 (de) Therapeutisch aktive wundauflagen, deren herstellung und deren verwendung
WO2004000094A8 (en) Predictive markers in cancer therapy
UA102236C2 (uk) Похідні еритропоетин-міметичного пептиду та їх фармацевтичні солі, їх одержання і застосування